FDA finalizes accelerated approval labeling guidance
The FDA on Tuesday finalized guidance on labeling drugs and biologics approved under the accelerated approval pathway.
The FDA’s accelerated approval program allows the agency …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.